EVO Q1 2026 Earnings Shares Rise Despite Significant EPS Miss SBDS Q1 2026 Earnings Significant Loss Reported Amidst Operational Challenges AAUC Q1 2026 Earnings Massive EPS Surprise of 8207 Driven by Strong Operational Performance Intelligent Bio Solutions Inc INBS Q1 2025 Earnings WiderThanExpected Loss Amid Continued PreRevenue Stage CF Q1 2026 Earnings Strong EPS Beat Offsets Flat Revenue Outlook Silo Pharma Inc SILO Rallies 399 as Biotech Sentiment Improves Key Levels in Focus Protalix BioTherapeutics PLX Gains on Biotechnology Sector Momentum Key Levels in Focus ECCV Edges Higher Bond Price Approaches Key Resistance Amid Steady Trading IDE Shares Retreat Amid Broader Market Pressure Key Support Levels in Focus MITQ Q1 2026 Earnings EPS at 004 as Revenue Details Remain Undisclosed